LncGata6 maintains stemness of intestinal stem cells and promotes intestinal tumorigenesis-Reference-Cited by-同舟云学术

LncGata6 maintains stemness of intestinal stem cells and promotes intestinal tumorigenesis

Published:2018-09-17 Issue:10 Volume:20 Page:1134-1144
ISSN:1465-7392
Container-title:Nature Cell Biology
language:en
Short-container-title:Nat Cell Biol

Author:

Zhu Pingping,Wu Jiayi,Wang Yanying,Zhu Xiaoxiao,Lu Tiankun,Liu Benyu,He Luyun,Ye Buqing,Wang Shuo,Meng Shu,Fan Dongdong,Wang Jing,Yang Liuliu,Qin Xiwen,Du Ying,Li Chong,He Lei,Ren Weizheng,Wu Xin,Tian Yong^ORCID,Fan Zusen^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology

Link

http://www.nature.com/articles/s41556-018-0194-0.pdf

Reference45 articles.

1. Huch, M. et al. In vitro expansion of single Lgr5+ liver stem cells induced by Wnt-driven regeneration. Nature 494, 247–250 (2013).

2. Barker, N. Adult intestinal stem cells: critical drivers of epithelial homeostasis and regeneration. Nat. Rev. Mol. Cell Biol. 15, 19–33 (2014).

3. Barker, N. et al. Identification of stem cells in small intestine and colon by marker gene Lgr5. Nature 449, 1003–1007 (2007).

4. Van der Flier, L. G. et al. Transcription factor achaete scute-like 2 controls intestinal stem cell fate. Cell 136, 903–912 (2009).

5. Van der Flier, L. G., Haegebarth, A., Stange, D. E., Van de Wetering, M. & Clevers, H. OLFM4 is a robust marker for stem cells in human intestine and marks a subset of colorectal cancer cells. Gastroenterology 137, 15–17 (2009).

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. H3K27ac-activated LncRNA NUTM2A-AS1 Facilitated the Progression of Colorectal Cancer Cells via MicroRNA-126-5p/FAM3C Axis;Current Cancer Drug Targets;2024-12

2. Unraveling the ncRNA landscape that governs colorectal cancer: A roadmap to personalized therapeutics;Life Sciences;2024-10

3. Long non-coding RNAs as pathophysiological regulators, therapeutic targets and novel extracellular vesicle biomarkers for the diagnosis of inflammatory bowel disease;Biomedicine & Pharmacotherapy;2024-07

4. Transcription factor EHF interacting with coactivator AJUBA aggravates malignancy and acts as a therapeutic target for gastroesophageal adenocarcinoma;Acta Pharmaceutica Sinica B;2024-05

5. IL-22, a vital cytokine in autoimmune diseases;Clinical and Experimental Immunology;2024-04-23